Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
AMWL 
American Well Corp (AMWL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/16/2025: AMWL (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
9 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $9.5
1 Year Target Price $9.5
| 1 | Strong Buy |
| 0 | Buy |
| 8 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -69.71% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/16/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 107.25M USD | Price to earnings Ratio - | 1Y Target Price 9.5 |
Price to earnings Ratio - | 1Y Target Price 9.5 | ||
Volume (30-day avg) 9 | Beta 1.28 | 52 Weeks Range 6.09 - 12.95 | Updated Date 09/16/2025 |
52 Weeks Range 6.09 - 12.95 | Updated Date 09/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -7.93 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -46.16% | Operating Margin (TTM) -28.74% |
Management Effectiveness
Return on Assets (TTM) -17.93% | Return on Equity (TTM) -37.62% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -105433117 | Price to Sales(TTM) 0.4 |
Enterprise Value -105433117 | Price to Sales(TTM) 0.4 | ||
Enterprise Value to Revenue 0.73 | Enterprise Value to EBITDA -0.82 | Shares Outstanding 14504800 | Shares Floating 12348435 |
Shares Outstanding 14504800 | Shares Floating 12348435 | ||
Percent Insiders 5.61 | Percent Institutions 44.02 |
Upturn AI SWOT
American Well Corp
Company Overview
History and Background
American Well Corp, now known as Amwell, was founded in 2006. It aimed to provide telehealth services connecting patients with doctors through online video consultations. Over time, it has expanded its platform and services to include various telehealth solutions for healthcare providers, insurers, and employers.
Core Business Areas
- Amwell Platform: Provides a comprehensive telehealth platform for various use cases, including acute care, behavioral health, and chronic condition management. Includes web and mobile applications for patients and providers.
- Amwell Medical Group: Employs a network of physicians, therapists and other healthcare professionals who provide telehealth consultations and services directly to patients.
- Converge: A new platform focused on hybrid care delivery, integrating in-person and virtual care workflows.
Leadership and Structure
Amwell is led by Ido Schoenberg, MD, Chairman and CEO. The organizational structure includes departments for technology, sales, marketing, medical operations, and finance.
Top Products and Market Share
Key Offerings
- Amwell Platform: A comprehensive platform for telehealth services, connecting patients with providers. While precise market share is difficult to quantify due to the fragmented telehealth market, Amwell is a major player with a significant number of active users among health systems and insurers. Competitors include Teladoc, Doctor on Demand, and MDLive.
- Amwell Medical Group: Employs physicians and therapists who provide telehealth consultations directly. Revenue figures are not typically broken out separately. Competitors include Teladoc's own physician network and other direct-to-consumer telehealth providers.
- Converge: A hybrid care delivery platform, integrating virtual and in-person care. Market share and revenue information for this newer product is not readily available. Competitors include other telehealth platform providers offering hybrid care solutions.
Market Dynamics
Industry Overview
The telehealth industry is experiencing significant growth driven by increasing demand for remote healthcare services, technological advancements, and regulatory changes. The market is highly competitive, with numerous players offering various telehealth solutions.
Positioning
Amwell is positioned as a leading telehealth platform provider, offering a comprehensive suite of services for healthcare providers, insurers, and employers. Its competitive advantages include its established platform, large network of providers, and strong relationships with major healthcare organizations.
Total Addressable Market (TAM)
The global telehealth market is projected to reach hundreds of billions of dollars in the coming years. Amwell is positioned to capture a significant portion of this TAM by providing a comprehensive and scalable telehealth platform.
Upturn SWOT Analysis
Strengths
- Established telehealth platform
- Large network of providers
- Strong relationships with healthcare organizations
- Comprehensive suite of services
- Converge hybrid care platform
Weaknesses
- Historical Losses
- Competition from larger, more diversified players
- Dependence on key partnerships
- Integration challenges with healthcare systems
- Need to prove Converge success
Opportunities
- Expanding telehealth adoption
- Growth in chronic condition management
- Partnerships with new healthcare providers
- Integration with emerging technologies
- Expansion into new geographic markets
Threats
- Increasing competition
- Changes in regulations
- Reimbursement challenges
- Data security risks
- Economic downturn impacting healthcare spending
Competitors and Market Share
Key Competitors
- TDOC
- LVGO
- ONEM
Competitive Landscape
Amwell faces intense competition from larger and more diversified players like Teladoc. Amwell's advantage lies in its established platform and partnerships, but it needs to improve profitability and demonstrate the success of its newer initiatives.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been driven by increasing telehealth adoption, but has also been impacted by volatility and market saturation.
Future Projections: Analyst projections typically forecast continued revenue growth, but profitability remains a key challenge. Requires real-time analyst data.
Recent Initiatives: Recent initiatives include the launch of Converge, expansion of partnerships, and focus on improving platform functionality.
Summary
Amwell is a key player in the telehealth space, leveraging its established platform and partnerships with healthcare providers. However, it faces significant competition and has struggled with profitability. The success of its Converge platform and managing integration challenges will be critical to its future growth. Amwell must manage reimbursement challenges and adapt to evolving regulations.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Investor Presentations
- Earnings Call Transcripts
- Industry Reports (e.g., from Gartner, Forrester)
- Market Research Reports
- News Articles
Disclaimers:
The data provided is for informational purposes only and should not be considered financial advice. Market share figures are estimates and may vary depending on the source. Financial data may be outdated. Consult a financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Well Corp
Exchange NYSE | Headquaters Boston, MA, United States | ||
IPO Launch date 2020-09-17 | Chairman & CEO Dr. Ido Schoenberg M.D. | ||
Sector Healthcare | Industry Health Information Services | Full time employees 877 | Website https://business.amwell.com |
Full time employees 877 | Website https://business.amwell.com | ||
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as offers specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members. It also provides Carepoint devices, which transforms proprietary carts, peripherals, tablets, and TVs into digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.